CLOV Is Set to Hold the Position Until 2022

During the last session 6M of Clover Health Investments, Corp.’s (NasdaqGS:CLOV) shares were traded. The stock closed at $7.27 per share indicating that it lost -$0.11 or -1.49% during that day which brings the Clover Health Investments, Corp.’s valuation to $1.84B.

The 52-week high for the Clover Health Investments, Corp.’s shares is $28.85. That puts it -74.8% from that peak but still a fine gain since the share price dropped to a 52-week low of $6.31, while the S&P 500’s share price change was of 37.51%.


What does the trading volume tell us about the CLOV stock?

During the last trading session, Clover Health Investments, Corp. (NasdaqGS:CLOV) has seen decay in its daily volume. The daily volume was of 23M, while in the last 10 days the average was 10.24M and last three months – 23.16M.

Growing short interest

The Clover Health Investments, Corp.’s shares are seeing an increasing short interest compared to the previous month. As of today, there are 31.02M shares being shorted which translates into 0.98 of a short ratio for CLOV, while in the previous month the shorted shares were 30.27M.

Clover Health Investments, Corp. (NasdaqGS:CLOV)’s financials

With a market cap of $1.84B, Clover Health Investments, Corp. holds a total cash of $607.15M that translates into $1.48 per share, while the total debt is of $29.14M.

The company has seen an increase in the revenue with a year-over-year quarterly revenue growth percentage of 109.70%. The current revenue is of $921.74M that is $4.69 per share.

This is a great sign for a bright future.